PF4 and neoplasm: Another important role of CXCR3 ligands in anti-tumor immunity relies on the effectiveness of CXCL4 and CXCL4L1 (factors produced by platelets) at inhibiting lymphangiogenesis and preventing metastatic escape of tumor cells via the lymphatic vasculature (17).